Literature DB >> 9023269

Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.

L F Tseng1, M Narita, H Mizoguchi, K Kawai, A Mizusuna, J Kamei, T Suzuki, H Nagase.   

Abstract

The effects of enantiomorphs of TAN-67 (2-methyl-4a alpha-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12a alpha-octahydro-quinolino[2,3,3-g]isoquinoline), (-)TAN-67 and (+)TAN-67, given intrathecally (i.t.) on antinociceptive response with the tail-flick test were studied in male ICR mice. (-)TAN-67 at doses from 17.9 to 89.4 nmol given i.t. produced a dose- and time-dependent inhibition of the tail-flick response, whereas its enantiomer (+)TAN-67 even at smaller doses (1.8, 4.5 and 8.9 nmol) given i.t. decreased the latencies of the tail-flick response. In addition, (+)TAN-67 at higher doses (17.9-89.4 nmol) given i.t. produced scratching and biting pain-like responses. The antinociceptive response induced by i.t.-administered (-)TAN-67 was mediated by the stimulation of delta-1 but not by delta-2, mu or kappa opioid receptors, because the effect was blocked by the i.t. pretreatment with BNTX, but not by naltriben, [D-Phe-Cys-Tyr-[D-Try-Orn-Thr-Pen-Thr-NH2 or nor-binaltorphimine dihydrochloride. Pretreatment with (-)TAN-67 given i.t. 3 hr earlier attenuated the tail-flick inhibition induced by subsequent i.t. administration of (-)TAN-67 and by [D-Pen2,5]enkephalin (DPDPE). However, the tail-flick inhibition induced by [D-Ala2]deltorphin II, [D-Ala2,NMePhe4,Gly5-ol]enkephalin and U50,488H were not affected by (-)TAN-67 pretreatment. Conversely, pretreatment with DPDPE given i.t. 3 hr earlier attenuated the tail-flick inhibition induced by subsequent i.t. administration of (-)TAN-67 and by DPDPE. However, the tail-flick inhibition induced by [D-Ala2]deltorphin II was not affected by i.t. DPDPE pretreatment. It is concluded that (-)TAN-67 given i.t. produces delta-1 opioid receptor-mediated antinociception; on the other hand, its enantiomer (+)TAN-67 produces hyperalgesia. Present studies provide other evidence that delta-1 opioid receptors exist separated from delta-2 opioid receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9023269

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Activation of delta-opioid receptors reduces excitatory input to putative gustatory cells within the nucleus of the solitary tract.

Authors:  Mingyan Zhu; Young K Cho; Cheng-Shu Li
Journal:  J Neurophysiol       Date:  2008-11-19       Impact factor: 2.714

2.  Spinal μ and δ opioids inhibit both thermal and mechanical pain in rats.

Authors:  Audrey Normandin; Philippe Luccarini; Jean-Louis Molat; Louis Gendron; Radhouane Dallel
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

Review 3.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.

Authors:  Emily M Jutkiewicz; Sarah T Kaminsky; Kenner C Rice; John R Traynor; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2005-07-13       Impact factor: 4.030

5.  The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking.

Authors:  Carsten K Nielsen; Jeffrey A Simms; Jade J Bito-Onon; Rui Li; Subramaniam Ananthan; Selena E Bartlett
Journal:  Addict Biol       Date:  2011-02-11       Impact factor: 4.280

Review 6.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

7.  Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.

Authors:  H Beaudry; A Proteau-Gagné; Shuang Li; Y Dory; C Chavkin; L Gendron
Journal:  Neuroscience       Date:  2009-03-27       Impact factor: 3.590

Review 8.  The Delta-Opioid Receptor; a Target for the Treatment of Pain.

Authors:  Béatrice Quirion; Francis Bergeron; Véronique Blais; Louis Gendron
Journal:  Front Mol Neurosci       Date:  2020-05-05       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.